Comparison

MLN8237 (Alisertib) European Partner

Item no. M1752-200mg
Manufacturer AbMole
CASRN 1028486-01-2
Amount 200mg
Category
Type Inhibitors
Specific against other
Purity 0,9917
Citations Pediatric Phase 1 Trial and Pharmacokinetic Study of MLN8237, an Investigational Oral Selective Small Molecule Inhibitor of Aurora Kinase A: A Children's Oncology Group Phase 1 Consortium study. Mosse YP, et al . Clin Cancer Res. 2012 Sep 17. PMID: 22988055 . Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma. Matulonis UA, et al . Gynecol Oncol. 2012 Oct,127(1):63-9. PMID: 22772063 . Phase I Study of Aurora A Kinase Inhibitor MLN8237 in Advanced Solid Tumors: Safety, Pharmacokinetics, Pharmacodynamics, and Bioavailability of Two Oral Formulations. Dees EC, et al . Clin Cancer Res. 2012 Sep 11,18(17):4775-84. PMID: 22767670 . Phase I Pharmacokinetic/Pharmacodynamic Study of MLN8237, an Investigational, Oral, Selective Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors. Cervantes A, et al . Clin Cancer Res. 2012 Sep 1,18(17):4764-74. PMID: 22753585 . Additive effects of vorinostat and MLN8237 in pediatric leukemia, medulloblastoma, and neuroblastoma cell lines. Muscal JA, et al . Invest New Drugs. 2012 Jun 6. PMID: 22669335 .
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias Alisertib
Similar products MLN8237, Alisertib
Available
Target Information
Aurora Kinase
Molecular Weight
518, 92
Solubility
DMSO 26 mg/mL
Bioactivity information
MLN8237 (Alisertib) is a second-generation, orally bioavailable, highly selective Aurora kinase A inhibitor with IC50 of 61 nM.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 200mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close